Opana ER Articles
US FDA to allow generic copies of Endo's Opana
13 May 2013
Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion
21 December 2012
US FDA clears Mylan’s generic versions of Hyzaar and Cozaar and Watson’s copy of Lotrel; Watson settles with Endo
18 October 2010
Forest/Merz settle with Mylan and others of generic Namenda; Impax’ generic Opana cleared in USA
23 July 2010
Endo/Penwest settle Opana litigation
2 March 2009
FDA clears three new Opana ER strengths
10 March 2008
Showing 1-7 of 7 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
